Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Mice genetically modified to produce more CD109 in their skin had less inflammation and better healing with less scarring.

Moderate immune responses help hair growth, while excessive responses slow it down.

SLE affects lungs and kidneys similarly due to immune complexes.

Keloids can form at the site of a healed herpes zoster infection, but the reason is unclear.

Cutaneous calcinosis can be induced in young animals using certain compounds, but only in specific areas and with high mortality.

Intralesional triamcinolone is more effective than topical betamethasone for treating localized alopecia areata.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Blocking interferon-gamma might help treat various autoimmune diseases.

γδ T cells help control tissue scarring and blood vessel growth in response to foreign objects.

Topical glucocorticoids thin the skin and change collagen structure.

Hair regrowth was achieved using 5-Fluorouracil and Bleomycin for scalp atrophy caused by corticosteroids.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

Face transplant for a severe autoimmune disease patient was successful, improving appearance and function without disease relapse after three years.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Methotrexate caused a rare skin rash in a rheumatoid arthritis patient, which resolved after stopping the drug.

A patient's skin rash did not affect the area where a previous viral rash was healing, suggesting a rare immune response.

Thorough evaluation and surgery are crucial for managing rare ovarian tumors in postmenopausal women with high androgen levels.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Trichogerminoma is a rare, benign skin tumor from hair cells, with a small risk of becoming cancerous.

A new skin cancer can develop where shingles once occurred.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

A woman with a scalp infection and herpes recovered fully after treatment.

The study found that sweat glands normally suppress immune responses, but this is disrupted in certain skin diseases, possibly contributing to their development.

The silk fibroin-based hydrogel shows promise for treating melanoma and healing infected wounds by killing tumor cells and bacteria, and supporting skin recovery.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Methotrexate injection site reactions are rare but can be managed by changing injection sites and using topical treatments.